Bavarian Nordic A/S (OCSE:BAVA) Accounts Payable & Accrued Expense : kr621 Mil (As of Mar. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Bavarian Nordic A/S Accounts Payable & Accrued Expense?

Bavarian Nordic A/S's quarterly accounts payable & accrued expense increased from Sep. 2023 (kr977 Mil) to Dec. 2023 (kr1,173 Mil) but then declined from Dec. 2023 (kr1,173 Mil) to Mar. 2024 (kr621 Mil).

Bavarian Nordic A/S's annual accounts payable & accrued expense increased from Dec. 2021 (kr336 Mil) to Dec. 2022 (kr730 Mil) and increased from Dec. 2022 (kr730 Mil) to Dec. 2023 (kr1,173 Mil).

Bavarian Nordic A/S Accounts Payable & Accrued Expense Historical Data

The historical data trend for Bavarian Nordic A/S's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic A/S Accounts Payable & Accrued Expense Chart

Bavarian Nordic A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

170.84

447.05

335.85

730.43

1,173.47

Bavarian Nordic A/S Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															536.65	923.62	977.29	1,173.47	621.48

Bavarian Nordic A/S Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Bavarian Nordic A/S (OCSE:BAVA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (OCSE:BAVA) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

BVNRY:USA BVNKF:USA BAVAc:UK 0DPB:UK BV3:Germany

Address

Philip Heymans Alle 3, Hellerup, DNK, DK-2900

Website

https://www.bavarian-nordic.com

Bavarian Nordic A/S is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets.

Bavarian Nordic A/S (OCSE:BAVA) Headlines

No Headlines